[go: up one dir, main page]

UA95293C2 - Vaccines for malaria - Google Patents

Vaccines for malaria

Info

Publication number
UA95293C2
UA95293C2 UAA200900210A UAA200900210A UA95293C2 UA 95293 C2 UA95293 C2 UA 95293C2 UA A200900210 A UAA200900210 A UA A200900210A UA A200900210 A UAA200900210 A UA A200900210A UA 95293 C2 UA95293 C2 UA 95293C2
Authority
UA
Ukraine
Prior art keywords
protein
particle
hepatitis
antigen
same
Prior art date
Application number
UAA200900210A
Other languages
Russian (ru)
Inventor
Джозеф Д. Коэн
Мартин Маршан
Кристиан Ф. Оукенгаус
Анджали Ядава
Original Assignee
Глаксосмиткляйн Байолоджикалз С.А.
Зе Юнайтед Стейтс Оф Америка, Эз Репрезентид Бай Зе Секретари Оф Зе Арми
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмиткляйн Байолоджикалз С.А., Зе Юнайтед Стейтс Оф Америка, Эз Репрезентид Бай Зе Секретари Оф Зе Арми filed Critical Глаксосмиткляйн Байолоджикалз С.А.
Publication of UA95293C2 publication Critical patent/UA95293C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against :he protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. In particular it relates to an immunogenic protein particle comprising the following monomers: a. a fusion protein comprising sequences derived from a CS protein of P.vivax and the S antigen of Hepatitis B (CSV-S), and b. a fusion protein comprising sequences derived from CS protein of P. falclparum and S antigen of Hepatitis B (RTS), and c optionally the S antigen derived from Hepatitis B.
UAA200900210A 2006-07-18 2007-07-16 Vaccines for malaria UA95293C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0614254.1A GB0614254D0 (en) 2006-07-18 2006-07-18 Vaccine

Publications (1)

Publication Number Publication Date
UA95293C2 true UA95293C2 (en) 2011-07-25

Family

ID=36998268

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200900211A UA99711C2 (en) 2006-07-18 2007-07-16 Vaccines for malaria
UAA200900210A UA95293C2 (en) 2006-07-18 2007-07-16 Vaccines for malaria

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200900211A UA99711C2 (en) 2006-07-18 2007-07-16 Vaccines for malaria

Country Status (3)

Country Link
CN (2) CN101553249A (en)
GB (1) GB0614254D0 (en)
UA (2) UA99711C2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997647A (en) * 1987-03-30 1991-03-05 New York University Vaccine against the sporozoite stage of malaria
SG48390A1 (en) * 1991-11-16 1998-04-17 Smithkline Beecham Biolog Hybrid protein between cs from plasmodium and hbs ag
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
GB0614254D0 (en) 2006-08-30
CN101522212A (en) 2009-09-02
UA99711C2 (en) 2012-09-25
CN101553249A (en) 2009-10-07

Similar Documents

Publication Publication Date Title
MX2009000655A (en) Vaccines for malaria.
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
WO2007095318A3 (en) Influenza antigens, vaccine compositions, and related methods
EA201000207A1 (en) NEW IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY
MX2010006984A (en) Vaccines for malaria.
WO2007067681A3 (en) Immunostimulatory compositions and methods
WO2018193063A3 (en) Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to
WO2007095320A3 (en) Hpv antigens, vaccine compositions, and related methods
WO2010044889A3 (en) Torque teno virus (ttv) isolates and compositions
EA200970586A1 (en) HUMAN CYTOMEGAL VIRUS ANTIBODIES (HCMV)
WO2009154995A3 (en) Interleukin 10 receptor (il-10r) antibodies and methods of use
WO2008134643A3 (en) Trypanosoma antigens, vaccine compositions, and related methods
WO2008033966A3 (en) Alphavirus replicon particles matched to protein antigens as immunological adjuvants
WO2011007961A3 (en) Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes
MA32388B1 (en) IMMUNOMODULATION WITH IPA INHIBITORS
WO2005007673A3 (en) Immunogenic peptides
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
WO2007016715A3 (en) Immune response inducing preparations
MX2011006516A (en) Hepatitis c virus combination therapy.
MX2011004176A (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same.
UA95293C2 (en) Vaccines for malaria
UY31574A1 (en) VACCINES AGAINST MALARIA
MX2007002659A (en) Vaccine composition against hepatitis c virus.
MX2012004448A (en) Infectious clones of torque teno virus.
PL391384A1 (en) Ribosomal P protein complex of Plasmodium falciparum as an antigen of malarial pathogen and process for the preparation of this antigen and expression cassette, especially for this process